Our group provides Precision Oncology based on genomic information. Based on the genomic information, which is the blueprint of cancer, we determine immunotherapy and molecularly targeted drugs and propose a treatment strategy optimized for each patient. Experts from various fields have come together to actively disseminate medical information along with the popularization of advanced medical care in the private practice sector.
FACT BOX
- Source: PR TIMES
- Category: News
- Products / services: SynerTri Immunotherapy®